Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists dig into fat tissue to unlock secrets of obesity surgery

NCT ID NCT02024542

First seen May 22, 2026 · Last updated Jun 19, 2026 · Updated 5 times

Summary

This study looks at genetic and chemical markers in fat tissue from 500 people with severe obesity who are having weight-loss surgery. Researchers collect a small amount of belly fat during the operation and take blood samples afterward. The goal is to understand why some patients have more health problems like diabetes than others, and how the body responds to surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MORBID OBESITY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of California Davis Medical Center

    RECRUITING

    Sacramento, California, 95817, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this research could help doctors better predict who will benefit most from bariatric surgery and why.

What could go wrong

This is an observational study, not a treatment trial. It collects data during surgery but does not test a new therapy, so direct patient benefits are uncertain.

Conditions

The condition(s) this trial relates to.

diabetes mellitus liver disorder metabolic syndrome X morbid obesity Obesity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.